Radioligands for tropomyosin receptor kinase (TRK) positron emission tomography

被引：0
|
作者：
Thiel, A. [1 ,2 ]
Bernard-Gauthier, V. [3 ]
Bailey, J. J. [3 ]
Kaiser, L. [4 ]
Bartenstein, P. [4 ]
Scott, P. [5 ]
Schirrmacher, R. [3 ]
机构：
[1] McGill Univ, McConnell Brain Imaging Ctr, Montreal Neurol Inst, 3801 Univ St, Montreal, PQ H3A 2B4, Canada
[2] Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ HT3 1E2, Canada
[3] Univ Alberta, Div Oncol Imaging, Dept Oncol, Edmonton, AB T6G 2R3, Canada
[4] Ludwig Maximilians Univ Munchen, Dept Nucl Med, Marchioninistr 15, D-81377 Munich, Germany
[5] Univ Michigan, Dept Radiol, Med Sch, Div Nucl Med, Ann Arbor, MI 48109 USA
来源：
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM | 2019年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PP01-M08
引用
收藏
页码：529 / 530
页数：2
相关论文
共 50 条
  • [1] Radioligands for Tropomyosin Receptor Kinase (Trk) Positron Emission Tomography Imaging
    Schirrmacher, Ralf
    Bailey, Justin J.
    Mossine, Andrew V.
    Scott, Peter J. H.
    Kaiser, Lena
    Bartenstein, Peter
    Lindner, Simon
    Kaplan, David R.
    Kostikov, Alexey
    Fricker, Gert
    Mahringer, Anne
    Rosa-Neto, Pedro
    Schirrmacher, Esther
    Waengler, Carmen
    Waengler, Bjoern
    Thiel, Alexander
    Soucy, Jean-Paul
    Bernard-Gauthier, Vadim
    PHARMACEUTICALS, 2019, 12 (01)
  • [2] Radioligands for positron emission tomography imaging of cannabinoid type 2 receptor
    Spinelli, Francesco
    Mu, Linjing
    Ametamey, Simon M.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2018, 61 (03): : 299 - 308
  • [3] Positron emission tomography radioligands for the opioid system
    Dannals, Robert F.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2013, 56 (3-4): : 187 - 195
  • [4] New potent A1 adenosine receptor radioligands for positron emission tomography
    Kreft, Sabrina
    Bier, Dirk
    Holschbach, Marcus H.
    Schulze, Annette
    Coenen, Heinz H.
    NUCLEAR MEDICINE AND BIOLOGY, 2017, 44 : 69 - 77
  • [5] Research Progress of Tropomyosin Receptor Kinase (TRK) Inhibitors
    Yang, Junzhe
    Xu, Zichao
    Li, Chunpu
    Cheng, Yuanzheng
    Liu, Hong
    CHINESE JOURNAL OF ORGANIC CHEMISTRY, 2022, 42 (07) : 2055 - 2069
  • [6] Positron emission tomography radioligands for in vivo imaging of Aβ plaques
    Mason, N. Scott
    Mathis, Chester A.
    Klunk, William E.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2013, 56 (3-4): : 89 - 95
  • [7] Identification of tropomyosin kinase receptor (TRK) mutations in cancer.
    Nanda, Nisha
    Fennell, Tim
    Low, Jennifer A.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [8] Tropomyosin Receptor Kinase Inhibitors for the Treatment of TRK Fusion Cancer
    Laetsch, Theodore W.
    Hong, David S.
    CLINICAL CANCER RESEARCH, 2021, 27 (18) : 4974 - 4982
  • [9] Synthesis and Evaluation of Novel Radioligands for Positron Emission Tomography Imaging of the Orexin-2 Receptor
    Oi, Norihito
    Suzuki, Michiyuki
    Terauchi, Taro
    Tokunaga, Masaki
    Nakatani, Yosuke
    Yamamoto, Noboru
    Fukumura, Toshimitsu
    Zhang, Ming-Rong
    Suhara, Tetsuya
    Higuchi, Makoto
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (16) : 6371 - 6385
  • [10] Synthesis and Evaluation of Novel Radioligands for Positron Emission Tomography Imaging of the Orexin-2 Receptor
    Oi, Norihito
    Suzuki, Michiyuki
    Terauchi, Taro
    Tokunaga, Masaki
    Nakatani, Yosuke
    Ymamoto, Noboru
    Fukumura, Toshimitsu
    Zhang, Ming-Rong
    Suhara, Tetsuya
    Higuchi, Makoto
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2014, 124 : 77P - 77P
12345